
Currently out of the existing stock ratings of Thomas Yip, 10 are a BUY (100%).
Analyst Thomas Yip, currently employed at B. RILEY, has had 33.33% of price targets met with an average potential upside of 31.57%, reached in 255 days on average.
Thomas Yip has documented 20 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OMER, Omeros at 17-Oct-2016.
Analyst best performing recommendations are on GERN (GERON).
The best stock recommendation documented was for GERN (GERON) on 9/19/2016. The price target of $5 was fulfilled within 549 days with a profit of $3 (150%), with a performance score of 2.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2026
$4
$2.01 (101.01%)
6 months 16 days ago
(01-May-2026)
0/2 (0%)
$1.28 (47.06%)
Buy Since 03-Aug-2018
$5
$5
1 years 2 months 5 days ago
(12-Sep-2025)
0/8 (0%)
$3.77 (306.50%)
Buy Since 15-Jun-2020
$4
$4
1 years 3 months 6 days ago
(11-Aug-2025)
0/7 (0%)
$2.75 (220.00%)
Buy Since 03-May-2024
$4
$4
1 years 8 months 27 days ago
(21-Feb-2025)
0/2 (0%)
$2.35 (142.42%)
Buy Since 27-Aug-2019
$3
$6
2 years 1 months ago
(17-Oct-2024)
3/10 (30%)
$1.37 (84.05%)
368
What Year was the first public recommendation made by Thomas Yip?